MedPath
Found 21 clinical trials|View Analysis
Sort by:

Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction

Phase 3
Recruiting
Conditions
Acute Myocardial Infarction of Anterior Wall
Left Ventricular Thrombus
Prophylaxis
Interventions
Drug: Apixaban 2.5 MG PO BID
Drug: Control (Standard treatment)
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
472
Registration Number
NCT06742567
Locations
🇵🇰

NICVD Pakistan, Karachi, Sindh, Pakistan

Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction

Phase 4
Not yet recruiting
Conditions
Left Ventricular Thrombus
Acute Myocardial Infarction
Interventions
First Posted Date
2024-07-23
Last Posted Date
2024-07-29
Lead Sponsor
Karolinska Institutet
Target Recruit Count
212
Registration Number
NCT06515730

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy

Not yet recruiting
Conditions
Left Ventricular Thrombus
Interventions
Other: Primary percutaneous coronary intervention or thrombolytic therapy
First Posted Date
2023-12-01
Last Posted Date
2023-12-01
Lead Sponsor
Assiut University
Target Recruit Count
400
Registration Number
NCT06152939

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

Phase 4
Recruiting
Conditions
STEMI - ST Elevation Myocardial Infarction
Interventions
Drug: DAPT
Drug: NOAC+DAPT
First Posted Date
2023-08-28
Last Posted Date
2024-03-19
Lead Sponsor
Zunyi Medical College
Target Recruit Count
374
Registration Number
NCT06013020
Locations
🇨🇳

Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial

Phase 4
Recruiting
Conditions
Left Ventricular Thrombus
Interventions
First Posted Date
2023-08-02
Last Posted Date
2023-08-02
Lead Sponsor
Peshawar Institute of Cardiology
Target Recruit Count
141
Registration Number
NCT05973188
Locations
🇵🇰

Peshawar Institute of Cardiology, Peshawar, KPK, Pakistan

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

Not Applicable
Recruiting
Conditions
ST-segment Elevation Myocardial Infarction (STEMI)
Left Ventricular Thrombus
Interventions
First Posted Date
2023-06-07
Last Posted Date
2023-06-07
Lead Sponsor
Jilin University
Target Recruit Count
320
Registration Number
NCT05892042
Locations
🇨🇳

Jilin university, Chang chun, Jilin, China

Anticoagulation in Post MI LV Thrombus Trial in Nepal

Phase 4
Recruiting
Conditions
Left Ventricular Thrombus
Myocardial Infarction
Interventions
First Posted Date
2023-04-03
Last Posted Date
2024-04-17
Lead Sponsor
Shahid Gangalal National Heart Centre
Target Recruit Count
196
Registration Number
NCT05794399
Locations
🇳🇵

Nepal Health Research Council, Kathmandu, Bagmati, Nepal

Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI

Phase 3
Completed
Conditions
ST Segment Elevation Myocardial Infarction
Left Ventricular Thrombus
Interventions
First Posted Date
2023-01-30
Last Posted Date
2023-04-07
Lead Sponsor
Rajaie Cardiovascular Medical and Research Center
Target Recruit Count
50
Registration Number
NCT05705089
Locations
🇮🇷

Rajaie Cardiovascular Medical and Research Center, Tehran, Iran, Islamic Republic of

🇮🇷

Tehran Heart Center, Tehran, Iran, Islamic Republic of

Apixaban in Patients With Left Ventricular Thrombus

Phase 3
Completed
Conditions
Left Ventricular Thrombus
Interventions
First Posted Date
2022-01-26
Last Posted Date
2022-01-26
Lead Sponsor
Saud Al Babtain Cardiac Center
Target Recruit Count
50
Registration Number
NCT05208398
Locations
🇸🇦

Saud AlBabtain Cardiac Center, Dammam, Saudi Arabia

Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF

Phase 3
Completed
Conditions
Myocardial Infarction, Acute
Left Ventricular Thrombus
Interventions
First Posted Date
2021-10-14
Last Posted Date
2024-07-10
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
560
Registration Number
NCT05077683
Locations
🇫🇷

HEGP, Paris, France

© Copyright 2025. All Rights Reserved by MedPath